nature.com
Expanding applications of therapies based on GLP1 - Nature Reviews Endocrinology
The evidence base in support of the use of medicines based on glucagon-like peptide 1 beyond glucose control and weight loss was substantially bolstered in 2024, as clinical trial data report benefits...